Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Obesity Surgery
Erschienen in: Obesity Surgery 5/2018

29.03.2018 | Original Contributions

Mini Gastric Bypass-One Anastomosis Gastric Bypass (MGB-OAGB)-IFSO Position Statement

verfasst von: Maurizio De Luca, Tiffany Tie, Geraldine Ooi, Kelvin Higa, Jacques Himpens, Miguel-A Carbajo, Kamal Mahawar, Scott Shikora, Wendy A. Brown

Erschienen in: Obesity Surgery | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Preamble

The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has played an integral role in educating both the metabolic surgical and the medical community at large about the role of innovative and new surgical and/or endoscopic interventions in treating adiposity-based chronic diseases.
The mini gastric bypass is also known as the one anastomosis gastric bypass. The IFSO has agreed that the standard nomenclature should be the mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB). The IFSO commissioned a task force (Appendix 1) to determine if MGB-OAGB is an effective and safe procedure and if it should be considered a surgical option for the treatment of obesity and metabolic diseases.
The following position statement is issued by the IFSO MGB-OAGB task force and approved by the IFSO Scientific Committee and Executive Board. This statement is based on current clinical knowledge, expert opinion, and published peer-reviewed scientific evidence. It will be reviewed in 2 years.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80.CrossRefPubMed
3.
Carbajo M, García-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15(3):398–404.CrossRefPubMed
4.
Lee WJ, Lin YH. Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence. Obes Surg. 2014;24(10):1749–56.CrossRefPubMed
5.
Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25(6):951–8.CrossRefPubMed
6.
Musella M, Milone M. Still "controversies" about the mini gastric bypass? Obes Surg. 2014;24(4):643–4.CrossRefPubMed
7.
Angrisani, L., et al., Bariatric surgery and Endoluminal procedures: IFSO worldwide survey 2014. Obes Surg, 2017.
8.
Blanc P, Lointier P, Breton C, et al. The hand-sewn anastomosis with an absorbable bidirectional monofilament barbed suture Stratafix during laparoscopic one anastomosis loop gastric bypass. Retrospective study in 50 patients. Obes Surg. 2015;25(12):2457–60.CrossRefPubMed
9.
Blanchet MC, Gignoux B, Matussière Y, et al. Experience with an enhanced recovery after surgery (ERAS) program for bariatric surgery: comparison of MGB and LSG in 374 patients. Obes Surg. 2017;27(7):1896–900.CrossRefPubMed
10.
Celik A, Pouwels S, Karaca FC, et al. Time to glycemic control—an observational study of 3 different operations. Obes Surg. 2017;27(3):694–702.CrossRefPubMed
11.
Dardzinska JA et al. Fasting and post-prandial peptide YY levels in obese patients before and after mini versus roux-en-Y gastric bypass. Minerva Chir. 2017;72(1):24–30.PubMed
12.
Garcia-Caballero M et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass. Nutricion Hospitalaria. 2012;27(2):623–31.PubMed
13.
Genser L, Carandina S, Tabbara M, et al. Presentation and surgical management of leaks after mini-gastric bypass for morbid obesity. Surgery for Obesity & Related Diseases. 2016;12(2):305–12.CrossRef
14.
Greco, F. and R. Tacchino, Ileal food diversion: a simple, powerful and easily revisable and reversible single-anastomosis gastric bypass. Obes Surg, 2014. 19.
15.
Kaska L, Proczko M, Wiśniewski P, et al. A prospective evaluation of the influence of three bariatric procedures on insulin resistance improvement. Should the extent of undiluted bile transit be considered a key postoperative factor altering glucose metabolism? Wideochir Inne Tech Maloinwazyjne. 2015;10(2):213–28.PubMedPubMedCentral
16.
Kim MJ, Park HK, Byun DW, et al. Incretin levels 1 month after laparoscopic single anastomosis gastric bypass surgery in non-morbid obese type 2 diabetes patients. Asian Journal of Surgery. 2014;37(3):130–7.CrossRefPubMed
17.
Kim Z, Hur KY. Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg. 2011;35(3):631–6.CrossRefPubMed
18.
Meydan C, Raziel A, Sakran N, et al. Single anastomosis gastric bypass-comparative short-term outcome study of conversional and primary procedures. Obes Surg. 2017;27(2):432–8.CrossRefPubMed
19.
Mokhber S et al. Anemia outcome after laparascopic mini bypass: analysis of 107 consecutive patients. Acta Gastroenterol Belg. 2016;79(2):201–5.PubMed
20.
Noun R, Riachi E, Zeidan S, et al. Mini-gastric bypass by mini-laparotomy: a cost-effective alternative in the laparoscopic era. Obes Surg. 2007;17(11):1482–6.CrossRefPubMed
21.
Piazza L, di Stefano C, Ferrara F, et al. Revision of failed primary adjustable gastric banding to mini-gastric bypass: results in 48 consecutive patients. Updat Surg. 2015;67(4):433–7.CrossRef
22.
Shenouda, M.M., et al., Bile gastritis following laparoscopic single anastomosis gastric bypass: pilot study to assess significance of bilirubin level in gastric aspirate. Obes Surg, 2017.
23.
24.
Betry C et al. Need for intensive nutrition care after bariatric surgery. JPEN J Parenter Enteral Nutr. 2017;41(2):258–62.CrossRefPubMed
25.
Garciacaballero M et al. Improvement of C peptide zero BMI 24-34 diabetic patients after tailored one anastomosis gastric bypass (BAGUA). Nutricion Hospitalaria. 2013;28(Suppl 2):35–46.PubMed
26.
Greco F. Conversion of vertical sleeve gastrectomy to a functional single-anastomosis gastric bypass: technique and preliminary results using a non-adjustable ring instead of stapled division. Obes Surg. 2017;27(4):896–901.CrossRefPubMed
27.
Himpens JM, Vilallonga R, Cadière GB, et al. Metabolic consequences of the incorporation of a roux limb in an omega loop (mini) gastric bypass: evaluation by a glucose tolerance test at mid-term follow-up. Surg Endosc. 2016;30(7):2935–45.CrossRefPubMed
28.
Milone M, di Minno MN, Leongito M, et al. Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol. 2013;19(39):6590–7.CrossRefPubMedPubMedCentral
29.
Tolone S, Cristiano S, Savarino E, et al. Effects of omega-loop bypass on esophagogastric junction function. Surgery for Obesity & Related Diseases. 2016;12(1):62–9.CrossRef
30.
Yeh C, Huang HH, Chen SC, et al. Comparison of consumption behavior and appetite sensations among patients with type 2 diabetes mellitus after bariatric surgery. PeerJ. 2017;5:e3090.CrossRefPubMedPubMedCentral
31.
Guo, X., et al., [Impacts of laparoscopic bariatric surgery on GLP-1 and Ghrelin level in patients with type 2 diabetes mellitus]. Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery], 2013. 51(4): p. 323–7.
32.
Guo X, Yin K, Zhuo GZ, et al. Efficacy comparison between 2 methods of laparoscopic gastric bypass surgery in the treatment of type 2 diabetes mellitus. Zhonghua Weichang Waike Zazhi. 2012;15(11):1125–8.PubMed
33.
Ding D, Chen DL, Hu XG, et al. Outcomes after laparoscopic surgery for 219 patients with obesity. Zhonghua Weichang Waike Zazhi. 2011;14(2):128–31.PubMed
34.
Lee WJ, Yu PJ, Wang W, et al. Laparoscopic roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242(1):20–8.CrossRefPubMedPubMedCentral
35.
Darabi S, Talebpour M, Zeinoddini A, et al. Laparoscopic gastric plication versus mini-gastric bypass surgery in the treatment of morbid obesity: a randomized clinical trial. Surgery for Obesity & Related Diseases. 2013;9(6):914–9.CrossRef
36.
Lee WJ, Chong K, Lin YH, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014;24(9):1552–62.CrossRefPubMed
37.
Seetharamaiah S, Tantia O, Goyal G, et al. LSG vs OAGB-1 year follow-up data-a randomized control trial. Obes Surg. 2017;27(4):948–54.CrossRefPubMed
38.
Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15(9):1304–8.CrossRefPubMed
39.
Noun R, Zeidan S. Laparoscopic mini-gastric bypass: an effective option for the treatment of morbid obesity. J Chir. 2007;144(4):301–4.CrossRef
40.
Peraglie C. Laparoscopic mini-gastric bypass (LMGB) in the super-super obese: outcomes in 16 patients. Obes Surg. 2008;18(9):1126–9.CrossRefPubMed
41.
Lee WJ, Wang W, Lee YC, et al. Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight. Obes Surg. 2008;18(3):294–9.CrossRefPubMed
42.
Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52.CrossRefPubMed
43.
Piazza L, Ferrara F, Leanza S, et al. Laparoscopic mini-gastric bypass: short-term single-institute experience. Updat Surg. 2011;63(4):239–42.CrossRef
44.
Lee WJ, Ser KH, Lee YC, et al. Laparoscopic roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22(12):1827–34.CrossRefPubMed
45.
Lee YC, Lee WJ, Liew PL. Predictors of remission of type 2 diabetes mellitus in obese patients after gastrointestinal surgery. Obesity Research & Clinical Practice. 2013;7(6):e494–500.CrossRef
46.
Lee YC, Liew PL, Lee WJ, et al. Gastrointestinal quality of life following bariatric surgery in Asian patients. Hepato-Gastroenterology. 2013;60(124):759–61.PubMed
47.
Carbajo MA, Jiménez JM, Castro MJ, et al. Outcomes in weight loss, fasting blood glucose and glycosylated hemoglobin in a sample of 415 obese patients, included in the database of the European accreditation council for excellence centers for bariatric surgery with laparoscopic one anastomosis gastric bypass. Nutricion Hospitalaria. 2014;30(5):1032–8.PubMed
48.
Kim MJ, Hur KY. Short-term outcomes of laparoscopic single anastomosis gastric bypass (LSAGB) for the treatment of type 2 diabetes in lower BMI (<30 kg/m(2)) patients. Obes Surg. 2014;24(7):1044–51.CrossRefPubMed
49.
Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses-first study from Indian subcontinent. Obes Surg. 2014;24(9):1430–5.CrossRefPubMed
50.
Musella, M., et al., A decade of bariatric surgery. What have we learned? Outcome in 520 patients from a single institution. International Journal Of Surgery, 2014. 12 Suppl 1: p. S183–8.
51.
Musella M, Susa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc. 2014;28(1):156–63.CrossRefPubMed
52.
Yang PJ, Lee WJ, Tseng PH, et al. Bariatric surgery decreased the serum level of an endotoxin-associated marker: lipopolysaccharide-binding protein. Surgery for Obesity & Related Diseases. 2014;10(6):1182–7.CrossRef
53.
Garcia-Caballero M et al. Super obese behave different from simple and morbid obese patients in the changes of body composition after tailored one anastomosis gastric bypass (BAGUA). Nutricion Hospitalaria. 2014;29(5):1013–9.PubMed
54.
Luger M, Kruschitz R, Langer F, et al. Effects of omega-loop gastric bypass on vitamin D and bone metabolism in morbidly obese bariatric patients. Obes Surg. 2015;25(6):1056–62.CrossRefPubMed
55.
Milone M, Lupoli R, Maietta P, et al. Lipid profile changes in patients undergoing bariatric surgery: a comparative study between sleeve gastrectomy and mini-gastric bypass. Int J Surg. 2015;14:28–32.CrossRefPubMed
56.
Kular KS, Manchanda N, Cheema GK. Seven years of mini-gastric bypass in type II diabetes patients with a body mass index <35 kg/m(2). Obes Surg. 2016;26(7):1457–62.CrossRefPubMed
57.
Peraglie C. Laparoscopic mini-gastric bypass in patients age 60 and older. Surg Endosc. 2016;30(1):38–43.CrossRefPubMed
58.
Al-Shurafa H et al. Primary experience of bariatric surgery in a newly established private obesity center. Saudi Medical Journal. 2016;37(10):1089–95.CrossRefPubMedPubMedCentral
59.
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, roux-en-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32.CrossRefPubMed
60.
Kansou, G., et al., Laparoscopic sleeve gastrectomy versus laparoscopic mini gastric bypass: One year outcomes. International Journal Of Surgery, 2016. 33 Pt A: p. 18–22.
61.
Kruschitz R, Luger M, Kienbacher C, et al. The effect of roux-en-Y vs. Omega-loop gastric bypass on liver, metabolic parameters, and weight loss. Obes Surg. 2016;26(9):2204–12.CrossRefPubMedPubMedCentral
62.
Musella M, Apers J, Rheinwalt K, et al. Efficacy of bariatric surgery in type 2 diabetes mellitus remission: the role of mini gastric bypass/one anastomosis gastric bypass and sleeve Gastrectomy at 1 year of follow-up. A European survey Obesity Surgery. 2016;26(5):933–40.CrossRefPubMed
63.
Karimi, M., et al., Trend of changes in serum albumin and its relation with sex, age, and BMI following laparoscopic mini-gastric bypass surgery in morbid obese cases. Obes Surg, 2017.
64.
Carbajo M, García-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15(3):398–404.CrossRefPubMed
65.
Wang W, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15(5):648–54.CrossRefPubMed
66.
Chakhtoura G, Zinzindohoué F, Ghanem Y, et al. Primary results of laparoscopic mini-gastric bypass in a French obesity-surgery specialized university hospital. Obes Surg. 2008;18(9):1130–3.CrossRefPubMed
67.
Noun R, Skaff J, Riachi E, et al. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697–703.CrossRefPubMed
68.
Disse E, Pasquer A, Espalieu P, et al. Greater weight loss with the omega loop bypass compared to the roux-en-Y gastric bypass: a comparative study. Obes Surg. 2014;24(6):841–6.CrossRefPubMed
69.
Bruzzi M, Rau C, Voron T, et al. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surgery for Obesity & Related Diseases. 2015;11(2):321–6.CrossRef
70.
Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25(6):951–8.CrossRefPubMed
71.
Guenzi M, Arman G, Rau C, et al. Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity. Surg Endosc. 2015;29(9):2669–74.CrossRefPubMed
72.
Parmar CD, Mahawar KK, Boyle M, et al. Mini gastric bypass: first report of 125 consecutive cases from United Kingdom. Clinical Obesity. 2016;6(1):61–7.CrossRefPubMed
73.
Madhok B, Mahawar KK, Boyle M, et al. Management of super-super obese patients: comparison between mini (one anastomosis) gastric bypass and sleeve gastrectomy. Obes Surg. 2016;26(7):1646–9.CrossRefPubMed
74.
Carbajo MA, Luque-de-León E, Jiménez JM, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27(5):1153–67.CrossRefPubMed
75.
Carbajo MA, Fong-Hirales A, Luque-de-León E, et al. Weight loss and improvement of lipid profiles in morbidly obese patients after laparoscopic one-anastomosis gastric bypass: 2-year follow-up. Surg Endosc. 2017;31(1):416–21.CrossRefPubMed
76.
Lessing Y, Pencovich N, Khatib M, et al. One-anastomosis gastric bypass: first 407 patients in 1 year. Obes Surg. 2017;27:2583–9.CrossRefPubMed
77.
Musella M, Susa A, Manno E, et al. Complications following the mini/one anastomosis gastric bypass (MGB/OAGB): a multi-institutional survey on 2678 patients with a mid-term (5 years) follow-up. Obes Surg. 2017;27:2956–67.CrossRefPubMed
78.
Taha O, Abdelaal M, Abozeid M, et al. Outcomes of omega loop gastric bypass, 6-years experience of 1520 cases. Obes Surg. 2017;27(8):1952–60.CrossRefPubMed
79.
Wang W, Huang MT, Wei PL, et al. Laparoscopic mini-gastric bypass for failed vertical banded gastroplasty. Obes Surg. 2004;14(6):777–82.CrossRefPubMed
80.
Moszkowicz D, Rau C, Guenzi M, et al. Laparoscopic omega-loop gastric bypass for the conversion of failed sleeve gastrectomy: early experience. Journal of visceral surgery. 2013;150(6):373–8.CrossRefPubMed
81.
Bruzzi M, Voron T, Zinzindohoue F, et al. Revisional single-anastomosis gastric bypass for a failed restrictive procedure: 5-year results. Surgery for Obesity & Related Diseases. 2016;12(2):240–5.CrossRef
82.
Salama TM, Sabry K. Redo surgery after failed open VBG: laparoscopic Minigastric bypass versus laparoscopic roux en Y gastric bypass-which is better? Minim Invasive Surg. 2016;2016:8737519.PubMedPubMedCentral
83.
Ghosh S, Bui TL, Skinner CE, et al. A 12-month review of Revisional single anastomosis gastric bypass for complicated laparoscopic adjustable gastric banding for body mass index over 35. Obes Surg. 2017;27:3048–54.CrossRefPubMed
84.
Chansaenroj P, Aung L, Lee WJ, et al. Revision procedures after failed adjustable gastric banding: comparison of efficacy and safety. Obes Surg. 2017;27:2861–7.CrossRefPubMed
85.
Chen CY, Lee WJ, Lee HM, et al. Laparoscopic conversion of gastric bypass complication to sleeve gastrectomy: technique and early results. Obes Surg. 2016;26(9):2014–21.CrossRefPubMed
86.
Chen MC, Lee YC, Lee WJ, et al. Diet behavior and low hemoglobin level after laparoscopic mini-gastric bypass surgery. Hepato-Gastroenterology. 2012;59(120):2530–2.PubMed
87.
Chiu CC, Lee WJ, Wang W, et al. Prevention of trocar-wound hernia in laparoscopic bariatric operations. Obes Surg. 2006;16(7):913–8.CrossRefPubMed
88.
Saarinen T, Räsänen J, Salo J, et al. Bile reflux scintigraphy after mini-gastric bypass. Obes Surg. 2017;27(8):2083–9.CrossRefPubMed
89.
Lee WJ, Lee YC, Ser KH, et al. Revisional surgery for laparoscopic minigastric bypass. Surgery for Obesity & Related Diseases. 2011;7(4):486–91.CrossRef
90.
Mahawar KK, Reed AN, Graham YNH. Marginal ulcers after one anastomosis (mini) gastric bypass: a survey of surgeons. Clin Obes. 2017;7(3):151–6.CrossRefPubMed
91.
Mishra T, Lakshmi KK, Peddi KK. Prevalence of cholelithiasis and choledocholithiasis in morbidly obese south Indian patients and the further development of biliary calculus disease after sleeve gastrectomy, gastric bypass and mini gastric bypass. Obes Surg. 2016;26(10):2411–7.CrossRefPubMed
92.
Rutledge R. Hospitalization before and after mini-gastric bypass surgery. Int J Surg. 2007;5(1):35–40.CrossRefPubMed
93.
Salama TMS, Hassan MI. Incidence of biliary reflux esophagitis after laparoscopic omega loop gastric bypass in morbidly obese patients. J Laparoendosc Adv Surg Tech A. 2017;27(6):618–22.CrossRefPubMed
Metadaten
Titel
Mini Gastric Bypass-One Anastomosis Gastric Bypass (MGB-OAGB)-IFSO Position Statement
verfasst von
Maurizio De Luca
Tiffany Tie
Geraldine Ooi
Kelvin Higa
Jacques Himpens
Miguel-A Carbajo
Kamal Mahawar
Scott Shikora
Wendy A. Brown
Publikationsdatum
29.03.2018
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 5/2018
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3182-3

Weitere Artikel der Ausgabe 5/2018

Obesity Surgery 5/2018 Zur Ausgabe

Original Contributions

Duodenal Exclusion but Not Sleeve Gastrectomy Preserves Insulin Secretion, Making It the More Effective Metabolic Procedure

Original Contributions

Single Anastomosis Duodenal-Ileal Bypass with Sleeve Gastrectomy/One Anastomosis Duodenal Switch (SADI-S/OADS) IFSO Position Statement

Original Contributions

Response Rates with the Spatz3 Adjustable Balloon

Original Contributions

Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery

Original Contributions

Management of Slipped Gastric Bands via Creation of a De Novo Tunnel and Band Replacement: a Single-Centre Experience

Biography

Khaled Gawdat, M.D.

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.